×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Primary Hyperoxaluria Market to Exhibit Substantial Growth Rate by 2032, Assesses DelveInsight | Leading ...
Yahoo Finance
The primary hyperoxaluria market is anticipated to witness an upsurge in growth in the coming years due to factors such as the increase in...
3 months ago
Gout Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - InventisBio, Allena ...
PR Newswire
PRNewswire/ -- DelveInsight's Gout Market Insights report includes a comprehensive understanding of current treatment practices,...
10 months ago
Late-stage Chronic Kidney Disease Market Outlook Report 2032 |
openPR.com
DelveInsight's "Late-stage Chronic Kidney Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth...
4 days ago
Allena Pharmaceuticals Shares Fall After Filing For Bankruptcy
Yahoo Finance
In its SEC filing, Allena Pharmaceuticals Inc (NASDAQ: ALNA) filed for chapter 11 bankruptcy protection and terminated the employment of...
20 months ago
Allena Pharmaceuticals Stock: A Double [Or More] Or Kaput In The Next 90 Days (ALNA)
Seeking Alpha
Summary · Allena Pharmaceuticals is trading below 10% of analyst price targets. · Allena Pharmaceuticals must identify a partner, secure a...
28 months ago
Allena, undeterred by two phase 2 flops, files for $92M IPO
Fierce Biotech
Third Rock Ventures-backed Allena Pharmaceuticals is about to put investors' renewed appetite for biotech IPOs to the test.
79 months ago
Allena Creates Oral Biologics To Treat Metabolic and Kidney Disorders
Clinical Leader
Allena Pharmaceuticals has quickly made the move from a discovery- to a clinical-stage company. Allena went public about eight months ago...
69 months ago
Allena Pharmaceuticals: a Penny Stock with Potential
TipRanks
Allena Pharmaceuticals (ALNA), a late-stage biopharmaceutical company, announced its Q2 results on Tuesday. The company develops oral enzyme therapeutics...
33 months ago
People
Nature
Recent moves of note in and around the biotech and pharma industries.
16 months ago
Reloxaliase Reduces Urinary Oxalate in Patients With Enteric Hyperoxaluria
Medical Professionals Reference
Allena Pharmaceuticals announced positive topline results from the phase 3 URIROX-1 trial of reloxaliase for the treatment of enteric...
54 months ago